Literature DB >> 3679064

Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers.

D Warot1, G Bensimon, P Danjou, A J Puech.   

Abstract

This study evaluated the effects of acute doses of zopiclone (7.5 mg), triazolam (0.25 mg) and placebo on memory and psychomotor performance of 12 normal volunteers. The subjects received both drugs in a repeated measure, double-blind Latin square design. The tests (CFF, CRT, DSST, memory assessments) were performed before and 2 and 6 hr after treatment. Zopiclone and triazolam induced an anterograde amnesia affecting short-term and long-term memory which lasted less than 6 hr. No retrograde amnesia was observed. Two hr after drug intake of both hypnotics psychomotor performances were significantly altered compared with placebo. The subjects also felt more drowsy, dizzy, clumsy and tired, and less alert and energetic 2 hr after zopiclone and triazolam compared to placebo. There was no difference between the effects of the two hypnotics at the doses studied.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679064     DOI: 10.1111/j.1472-8206.1987.tb00553.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  13 in total

1.  Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement.

Authors:  Jaime Meléndez; Irina Galli; Katica Boric; Alonso Ortega; Leonardo Zuñiga; Carlos F Henríquez-Roldán; Ana M Cárdenas
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

2.  Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests.

Authors:  T Kuitunen; M J Mattila; T Seppälä; K Aranko; M E Mattila
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.

Authors:  Francois Chavant; Sylvie Favrelière; Claire Lafay-Chebassier; Caroline Plazanet; Marie-Christine Pérault-Pochat
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

4.  Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.

Authors:  Hervé Allain; Danièle Bentué-Ferrer; Antoine Tarral; Jean-Marc Gandon
Journal:  Eur J Clin Pharmacol       Date:  2003-05-17       Impact factor: 2.953

Review 5.  The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam.

Authors:  G W Kunsman; J E Manno; B R Manno; C M Kunsman; M A Przekop
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

Review 6.  An assessment of short-acting hypnotics.

Authors:  W B Mendelson; B Jain
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

7.  Difference in action between oral triazolam and zopiclone.

Authors:  R Aantaa; M Salonen; T Nyrke
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Effects of daytime administration of zolpidem versus triazolam on memory.

Authors:  N J Wesensten; T J Balkin; G L Belenky
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 9.  Comparative tolerability of newer agents for insomnia.

Authors:  Gary Zammit
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Eszopiclone: its use in the treatment of insomnia.

Authors:  Jaime M Monti; S R Pandi-Perumal
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.